Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance
- PMID: 12760894
- PMCID: PMC155830
- DOI: 10.1128/AAC.47.6.2036-2039.2003
Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance
Abstract
Four clinical U.S. glycopeptide intermediate resistant Staphylococcus aureus (GISA) isolates were resistant to Triton X-100-induced autolysis. Similar resistance was demonstrated in an isolate obtained after a single passage of a susceptible clinical isolate in low-level vancomycin. Strains with the vancomycin-induced Triton X-100 resistance phenotype produced active murein hydrolases but were resistant to lysis by murein hydrolases.
Figures





Similar articles
-
Antimicrobial Activity of Galangin and Its Effects on Murein Hydrolases of Vancomycin-Intermediate Staphylococcus aureus (VISA) Strain Mu50.Chemotherapy. 2018;63(1):20-28. doi: 10.1159/000481658. Epub 2017 Nov 17. Chemotherapy. 2018. PMID: 29145175
-
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.Antimicrob Agents Chemother. 2002 May;46(5):1492-502. doi: 10.1128/AAC.46.5.1492-1502.2002. Antimicrob Agents Chemother. 2002. PMID: 11959587 Free PMC article.
-
Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains.J Antimicrob Chemother. 2005 Nov;56(5):944-7. doi: 10.1093/jac/dki289. Epub 2005 Sep 12. J Antimicrob Chemother. 2005. PMID: 16157619
-
The VISA/GISA problem: therapeutic implications.Clin Microbiol Infect. 2001;7 Suppl 4:8-15. doi: 10.1046/j.1469-0691.2001.00054.x. Clin Microbiol Infect. 2001. PMID: 11688538 Review.
-
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. doi: 10.1086/533592. Clin Infect Dis. 2008. PMID: 18462091 Review.
Cited by
-
VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.J Antimicrob Chemother. 2021 Jun 18;76(7):1712-1723. doi: 10.1093/jac/dkab113. J Antimicrob Chemother. 2021. PMID: 33948657 Free PMC article.
-
"Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.Antimicrob Agents Chemother. 2014 Sep;58(9):5024-35. doi: 10.1128/AAC.02470-13. Epub 2014 May 19. Antimicrob Agents Chemother. 2014. PMID: 24841271 Free PMC article.
-
First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.J Clin Microbiol. 2010 Jun;48(6):2199-204. doi: 10.1128/JCM.00954-09. Epub 2010 Apr 14. J Clin Microbiol. 2010. PMID: 20392906 Free PMC article.
-
SpoVG Regulates Cell Wall Metabolism and Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus Strain N315.Antimicrob Agents Chemother. 2016 May 23;60(6):3455-61. doi: 10.1128/AAC.00026-16. Print 2016 Jun. Antimicrob Agents Chemother. 2016. PMID: 27001809 Free PMC article.
-
Antimicrobial Resistance in ESKAPE Pathogens.Clin Microbiol Rev. 2020 May 13;33(3):e00181-19. doi: 10.1128/CMR.00181-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32404435 Free PMC article. Review.
References
-
- Blackman, S. A., T. J. Smith, and S. J. Foster. 1998. The role of autolysins during vegetative growth of Bacillus subtilis 168. Microbiology 144:73-82. - PubMed
-
- Boyle-Vavra, S., R. B. Carey, and R. S. Daum. 2001. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J. Antimicrob. Chemother. 48:617-625. - PubMed
-
- Boyle-Vavra, S., S. Stenberg, and R. S. Daum. 1997. Decreased triton-induced lysis in two vancomycin resistant Staphylococcus aureus mutants derived in the laboratory from clinical susceptible isolate 523. 97th General Meeting American Society for Microbiology Abstract A-131, Miami, Fla.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical